世界のJAK＆PI3Kシグナル伝達経路市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global JAK and PI3K Signaling Pathway Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5814
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、JAK＆PI3Kシグナル伝達経路の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PI3K、ヤヌスキナーゼ療法（阻害剤）、PI3K療法（阻害剤）、JAK・PI3Kシグナル伝達バイオマーカー）、用途別市場規模（がん、炎症性疾患、心臓病、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・JAK＆PI3Kシグナル伝達経路の市場動向
・企業の競争状況、市場シェア
・JAK＆PI3Kシグナル伝達経路の種類別市場規模と予測2016-2027（PI3K、ヤヌスキナーゼ療法（阻害剤）、PI3K療法（阻害剤）、JAK・PI3Kシグナル伝達バイオマーカー）
・JAK＆PI3Kシグナル伝達経路の用途別市場規模と予測2016-2027（がん、炎症性疾患、心臓病、その他）
・JAK＆PI3Kシグナル伝達経路の北米市場規模2016-2027（アメリカ、カナダ）
・JAK＆PI3Kシグナル伝達経路の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・JAK＆PI3Kシグナル伝達経路のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・JAK＆PI3Kシグナル伝達経路の中南米市場規模2016-2027（メキシコ、ブラジル）
・JAK＆PI3Kシグナル伝達経路の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bayer HealthCare Pharmaceuticals、AbbVie、AstraZeneca、Curis、Daiichi Sankyo、Exelixis、Genentech、Infinity Pharmaceuticals、Merck & Co.、Rigel Pharmaceuticals、TG Therapeutics、Sanofi Oncology、Vertex Pharmaceuticals、WILEX AG）
・結論

Therapies related to the JAK and PI3K signaling pathways have the potential to target diseases such as cancer and inflammatory diseases, and no suitable drugs are currently available. Current therapies can reduce the burden of disease, but they cannot be cured.
Significant progress has been made in understanding the complexity of signaling pathways such as JAK and PI3K over the past few years. At the same time, great progress has been made in the isolation of target-specific therapies / inhibitors targeting abnormal signals in these pathways. After approval of ruxolitinib (for bone marrow fibrosis) and tofacitinib (for rheumatoid arthritis), the treatment of JAK and PI3K cell signaling pathways has focused on cancer lines and inflammatory diseases.

Market Analysis and Insights: Global JAK and PI3K Signaling Pathway Market
The global JAK and PI3K Signaling Pathway market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global JAK and PI3K Signaling Pathway market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global JAK and PI3K Signaling Pathway market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global JAK and PI3K Signaling Pathway market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global JAK and PI3K Signaling Pathway market.

Global JAK and PI3K Signaling Pathway Scope and Market Size
JAK and PI3K Signaling Pathway market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global JAK and PI3K Signaling Pathway market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PI3K
Janus Kinase Therapies (Inhibitors)
PI3K Therapies (Inhibitors)
Signal Transduction Biomarkers for JAK and PI3K

Segment by Application
Cancer
Inflammatory Diseases
Cardiac Ailments
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer HealthCare Pharmaceuticals
AbbVie
AstraZeneca
Curis
Daiichi Sankyo
Exelixis
Genentech
Infinity Pharmaceuticals
Merck & Co.
Rigel Pharmaceuticals
TG Therapeutics
Sanofi Oncology
Vertex Pharmaceuticals
WILEX AG

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global JAK and PI3K Signaling Pathway Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PI3K
1.2.3 Janus Kinase Therapies (Inhibitors)
1.2.4 PI3K Therapies (Inhibitors)
1.2.5 Signal Transduction Biomarkers for JAK and PI3K
1.3 Market by Application
1.3.1 Global JAK and PI3K Signaling Pathway Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Inflammatory Diseases
1.3.4 Cardiac Ailments
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global JAK and PI3K Signaling Pathway Market Perspective (2016-2027)
2.2 JAK and PI3K Signaling Pathway Growth Trends by Regions
2.2.1 JAK and PI3K Signaling Pathway Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 JAK and PI3K Signaling Pathway Historic Market Share by Regions (2016-2021)
2.2.3 JAK and PI3K Signaling Pathway Forecasted Market Size by Regions (2022-2027)
2.3 JAK and PI3K Signaling Pathway Industry Dynamic
2.3.1 JAK and PI3K Signaling Pathway Market Trends
2.3.2 JAK and PI3K Signaling Pathway Market Drivers
2.3.3 JAK and PI3K Signaling Pathway Market Challenges
2.3.4 JAK and PI3K Signaling Pathway Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top JAK and PI3K Signaling Pathway Players by Revenue
3.1.1 Global Top JAK and PI3K Signaling Pathway Players by Revenue (2016-2021)
3.1.2 Global JAK and PI3K Signaling Pathway Revenue Market Share by Players (2016-2021)
3.2 Global JAK and PI3K Signaling Pathway Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by JAK and PI3K Signaling Pathway Revenue
3.4 Global JAK and PI3K Signaling Pathway Market Concentration Ratio
3.4.1 Global JAK and PI3K Signaling Pathway Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by JAK and PI3K Signaling Pathway Revenue in 2020
3.5 JAK and PI3K Signaling Pathway Key Players Head office and Area Served
3.6 Key Players JAK and PI3K Signaling Pathway Product Solution and Service
3.7 Date of Enter into JAK and PI3K Signaling Pathway Market
3.8 Mergers & Acquisitions, Expansion Plans

4 JAK and PI3K Signaling Pathway Breakdown Data by Type
4.1 Global JAK and PI3K Signaling Pathway Historic Market Size by Type (2016-2021)
4.2 Global JAK and PI3K Signaling Pathway Forecasted Market Size by Type (2022-2027)

5 JAK and PI3K Signaling Pathway Breakdown Data by Application
5.1 Global JAK and PI3K Signaling Pathway Historic Market Size by Application (2016-2021)
5.2 Global JAK and PI3K Signaling Pathway Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America JAK and PI3K Signaling Pathway Market Size (2016-2027)
6.2 North America JAK and PI3K Signaling Pathway Market Size by Type
6.2.1 North America JAK and PI3K Signaling Pathway Market Size by Type (2016-2021)
6.2.2 North America JAK and PI3K Signaling Pathway Market Size by Type (2022-2027)
6.2.3 North America JAK and PI3K Signaling Pathway Market Size by Type (2016-2027)
6.3 North America JAK and PI3K Signaling Pathway Market Size by Application
6.3.1 North America JAK and PI3K Signaling Pathway Market Size by Application (2016-2021)
6.3.2 North America JAK and PI3K Signaling Pathway Market Size by Application (2022-2027)
6.3.3 North America JAK and PI3K Signaling Pathway Market Size by Application (2016-2027)
6.4 North America JAK and PI3K Signaling Pathway Market Size by Country
6.4.1 North America JAK and PI3K Signaling Pathway Market Size by Country (2016-2021)
6.4.2 North America JAK and PI3K Signaling Pathway Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe JAK and PI3K Signaling Pathway Market Size (2016-2027)
7.2 Europe JAK and PI3K Signaling Pathway Market Size by Type
7.2.1 Europe JAK and PI3K Signaling Pathway Market Size by Type (2016-2021)
7.2.2 Europe JAK and PI3K Signaling Pathway Market Size by Type (2022-2027)
7.2.3 Europe JAK and PI3K Signaling Pathway Market Size by Type (2016-2027)
7.3 Europe JAK and PI3K Signaling Pathway Market Size by Application
7.3.1 Europe JAK and PI3K Signaling Pathway Market Size by Application (2016-2021)
7.3.2 Europe JAK and PI3K Signaling Pathway Market Size by Application (2022-2027)
7.3.3 Europe JAK and PI3K Signaling Pathway Market Size by Application (2016-2027)
7.4 Europe JAK and PI3K Signaling Pathway Market Size by Country
7.4.1 Europe JAK and PI3K Signaling Pathway Market Size by Country (2016-2021)
7.4.2 Europe JAK and PI3K Signaling Pathway Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific JAK and PI3K Signaling Pathway Market Size (2016-2027)
8.2 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Type
8.2.1 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Type (2016-2021)
8.2.2 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Type (2022-2027)
8.2.3 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Type (2016-2027)
8.3 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Application
8.3.1 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Application (2016-2021)
8.3.2 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Application (2022-2027)
8.3.3 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Application (2016-2027)
8.4 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Region
8.4.1 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Region (2016-2021)
8.4.2 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America JAK and PI3K Signaling Pathway Market Size (2016-2027)
9.2 Latin America JAK and PI3K Signaling Pathway Market Size by Type
9.2.1 Latin America JAK and PI3K Signaling Pathway Market Size by Type (2016-2021)
9.2.2 Latin America JAK and PI3K Signaling Pathway Market Size by Type (2022-2027)
9.2.3 Latin America JAK and PI3K Signaling Pathway Market Size by Type (2016-2027)
9.3 Latin America JAK and PI3K Signaling Pathway Market Size by Application
9.3.1 Latin America JAK and PI3K Signaling Pathway Market Size by Application (2016-2021)
9.3.2 Latin America JAK and PI3K Signaling Pathway Market Size by Application (2022-2027)
9.3.3 Latin America JAK and PI3K Signaling Pathway Market Size by Application (2016-2027)
9.4 Latin America JAK and PI3K Signaling Pathway Market Size by Country
9.4.1 Latin America JAK and PI3K Signaling Pathway Market Size by Country (2016-2021)
9.4.2 Latin America JAK and PI3K Signaling Pathway Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa JAK and PI3K Signaling Pathway Market Size (2016-2027)
10.2 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Type
10.2.1 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Type (2016-2021)
10.2.2 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Type (2022-2027)
10.2.3 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Type (2016-2027)
10.3 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Application
10.3.1 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Application (2016-2021)
10.3.2 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Application (2022-2027)
10.3.3 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Application (2016-2027)
10.4 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Country
10.4.1 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Country (2016-2021)
10.4.2 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer HealthCare Pharmaceuticals
11.1.1 Bayer HealthCare Pharmaceuticals Company Details
11.1.2 Bayer HealthCare Pharmaceuticals Business Overview
11.1.3 Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Introduction
11.1.4 Bayer HealthCare Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2016-2021)
11.1.5 Bayer HealthCare Pharmaceuticals Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie JAK and PI3K Signaling Pathway Introduction
11.2.4 AbbVie Revenue in JAK and PI3K Signaling Pathway Business (2016-2021)
11.2.5 AbbVie Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca JAK and PI3K Signaling Pathway Introduction
11.3.4 AstraZeneca Revenue in JAK and PI3K Signaling Pathway Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Curis
11.4.1 Curis Company Details
11.4.2 Curis Business Overview
11.4.3 Curis JAK and PI3K Signaling Pathway Introduction
11.4.4 Curis Revenue in JAK and PI3K Signaling Pathway Business (2016-2021)
11.4.5 Curis Recent Development
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Company Details
11.5.2 Daiichi Sankyo Business Overview
11.5.3 Daiichi Sankyo JAK and PI3K Signaling Pathway Introduction
11.5.4 Daiichi Sankyo Revenue in JAK and PI3K Signaling Pathway Business (2016-2021)
11.5.5 Daiichi Sankyo Recent Development
11.6 Exelixis
11.6.1 Exelixis Company Details
11.6.2 Exelixis Business Overview
11.6.3 Exelixis JAK and PI3K Signaling Pathway Introduction
11.6.4 Exelixis Revenue in JAK and PI3K Signaling Pathway Business (2016-2021)
11.6.5 Exelixis Recent Development
11.7 Genentech
11.7.1 Genentech Company Details
11.7.2 Genentech Business Overview
11.7.3 Genentech JAK and PI3K Signaling Pathway Introduction
11.7.4 Genentech Revenue in JAK and PI3K Signaling Pathway Business (2016-2021)
11.7.5 Genentech Recent Development
11.8 Infinity Pharmaceuticals
11.8.1 Infinity Pharmaceuticals Company Details
11.8.2 Infinity Pharmaceuticals Business Overview
11.8.3 Infinity Pharmaceuticals JAK and PI3K Signaling Pathway Introduction
11.8.4 Infinity Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2016-2021)
11.8.5 Infinity Pharmaceuticals Recent Development
11.9 Merck & Co.
11.9.1 Merck & Co. Company Details
11.9.2 Merck & Co. Business Overview
11.9.3 Merck & Co. JAK and PI3K Signaling Pathway Introduction
11.9.4 Merck & Co. Revenue in JAK and PI3K Signaling Pathway Business (2016-2021)
11.9.5 Merck & Co. Recent Development
11.10 Rigel Pharmaceuticals
11.10.1 Rigel Pharmaceuticals Company Details
11.10.2 Rigel Pharmaceuticals Business Overview
11.10.3 Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Introduction
11.10.4 Rigel Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2016-2021)
11.10.5 Rigel Pharmaceuticals Recent Development
11.11 TG Therapeutics
11.11.1 TG Therapeutics Company Details
11.11.2 TG Therapeutics Business Overview
11.11.3 TG Therapeutics JAK and PI3K Signaling Pathway Introduction
11.11.4 TG Therapeutics Revenue in JAK and PI3K Signaling Pathway Business (2016-2021)
11.11.5 TG Therapeutics Recent Development
11.12 Sanofi Oncology
11.12.1 Sanofi Oncology Company Details
11.12.2 Sanofi Oncology Business Overview
11.12.3 Sanofi Oncology JAK and PI3K Signaling Pathway Introduction
11.12.4 Sanofi Oncology Revenue in JAK and PI3K Signaling Pathway Business (2016-2021)
11.12.5 Sanofi Oncology Recent Development
11.13 Vertex Pharmaceuticals
11.13.1 Vertex Pharmaceuticals Company Details
11.13.2 Vertex Pharmaceuticals Business Overview
11.13.3 Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Introduction
11.13.4 Vertex Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2016-2021)
11.13.5 Vertex Pharmaceuticals Recent Development
11.14 WILEX AG
11.14.1 WILEX AG Company Details
11.14.2 WILEX AG Business Overview
11.14.3 WILEX AG JAK and PI3K Signaling Pathway Introduction
11.14.4 WILEX AG Revenue in JAK and PI3K Signaling Pathway Business (2016-2021)
11.14.5 WILEX AG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global JAK and PI3K Signaling Pathway Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PI3K
Table 3. Key Players of Janus Kinase Therapies (Inhibitors)
Table 4. Key Players of PI3K Therapies (Inhibitors)
Table 5. Key Players of Signal Transduction Biomarkers for JAK and PI3K
Table 6. Global JAK and PI3K Signaling Pathway Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global JAK and PI3K Signaling Pathway Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global JAK and PI3K Signaling Pathway Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global JAK and PI3K Signaling Pathway Market Share by Regions (2016-2021)
Table 10. Global JAK and PI3K Signaling Pathway Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global JAK and PI3K Signaling Pathway Market Share by Regions (2022-2027)
Table 12. JAK and PI3K Signaling Pathway Market Trends
Table 13. JAK and PI3K Signaling Pathway Market Drivers
Table 14. JAK and PI3K Signaling Pathway Market Challenges
Table 15. JAK and PI3K Signaling Pathway Market Restraints
Table 16. Global JAK and PI3K Signaling Pathway Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global JAK and PI3K Signaling Pathway Market Share by Players (2016-2021)
Table 18. Global Top JAK and PI3K Signaling Pathway Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in JAK and PI3K Signaling Pathway as of 2020)
Table 19. Ranking of Global Top JAK and PI3K Signaling Pathway Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by JAK and PI3K Signaling Pathway Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players JAK and PI3K Signaling Pathway Product Solution and Service
Table 23. Date of Enter into JAK and PI3K Signaling Pathway Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global JAK and PI3K Signaling Pathway Market Size by Type (2016-2021) (US$ Million)
Table 26. Global JAK and PI3K Signaling Pathway Revenue Market Share by Type (2016-2021)
Table 27. Global JAK and PI3K Signaling Pathway Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global JAK and PI3K Signaling Pathway Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global JAK and PI3K Signaling Pathway Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global JAK and PI3K Signaling Pathway Revenue Market Share by Application (2016-2021)
Table 31. Global JAK and PI3K Signaling Pathway Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global JAK and PI3K Signaling Pathway Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America JAK and PI3K Signaling Pathway Market Size by Type (2016-2021) (US$ Million)
Table 34. North America JAK and PI3K Signaling Pathway Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America JAK and PI3K Signaling Pathway Market Size by Application (2016-2021) (US$ Million)
Table 36. North America JAK and PI3K Signaling Pathway Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America JAK and PI3K Signaling Pathway Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America JAK and PI3K Signaling Pathway Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe JAK and PI3K Signaling Pathway Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe JAK and PI3K Signaling Pathway Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe JAK and PI3K Signaling Pathway Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe JAK and PI3K Signaling Pathway Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe JAK and PI3K Signaling Pathway Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe JAK and PI3K Signaling Pathway Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America JAK and PI3K Signaling Pathway Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America JAK and PI3K Signaling Pathway Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America JAK and PI3K Signaling Pathway Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America JAK and PI3K Signaling Pathway Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America JAK and PI3K Signaling Pathway Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America JAK and PI3K Signaling Pathway Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bayer HealthCare Pharmaceuticals Company Details
Table 64. Bayer HealthCare Pharmaceuticals Business Overview
Table 65. Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Product
Table 66. Bayer HealthCare Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million)
Table 67. Bayer HealthCare Pharmaceuticals Recent Development
Table 68. AbbVie Company Details
Table 69. AbbVie Business Overview
Table 70. AbbVie JAK and PI3K Signaling Pathway Product
Table 71. AbbVie Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million)
Table 72. AbbVie Recent Development
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca JAK and PI3K Signaling Pathway Product
Table 76. AstraZeneca Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Curis Company Details
Table 79. Curis Business Overview
Table 80. Curis JAK and PI3K Signaling Pathway Product
Table 81. Curis Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million)
Table 82. Curis Recent Development
Table 83. Daiichi Sankyo Company Details
Table 84. Daiichi Sankyo Business Overview
Table 85. Daiichi Sankyo JAK and PI3K Signaling Pathway Product
Table 86. Daiichi Sankyo Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million)
Table 87. Daiichi Sankyo Recent Development
Table 88. Exelixis Company Details
Table 89. Exelixis Business Overview
Table 90. Exelixis JAK and PI3K Signaling Pathway Product
Table 91. Exelixis Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million)
Table 92. Exelixis Recent Development
Table 93. Genentech Company Details
Table 94. Genentech Business Overview
Table 95. Genentech JAK and PI3K Signaling Pathway Product
Table 96. Genentech Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million)
Table 97. Genentech Recent Development
Table 98. Infinity Pharmaceuticals Company Details
Table 99. Infinity Pharmaceuticals Business Overview
Table 100. Infinity Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million)
Table 101. Infinity Pharmaceuticals Recent Development
Table 102. Merck & Co. Company Details
Table 103. Merck & Co. Business Overview
Table 104. Merck & Co. JAK and PI3K Signaling Pathway Product
Table 105. Merck & Co. Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million)
Table 106. Merck & Co. Recent Development
Table 107. Rigel Pharmaceuticals Company Details
Table 108. Rigel Pharmaceuticals Business Overview
Table 109. Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Product
Table 110. Rigel Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million)
Table 111. Rigel Pharmaceuticals Recent Development
Table 112. TG Therapeutics Company Details
Table 113. TG Therapeutics Business Overview
Table 114. TG Therapeutics JAK and PI3K Signaling Pathway Product
Table 115. TG Therapeutics Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million)
Table 116. TG Therapeutics Recent Development
Table 117. Sanofi Oncology Company Details
Table 118. Sanofi Oncology Business Overview
Table 119. Sanofi Oncology JAK and PI3K Signaling Pathway Product
Table 120. Sanofi Oncology Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million)
Table 121. Sanofi Oncology Recent Development
Table 122. Vertex Pharmaceuticals Company Details
Table 123. Vertex Pharmaceuticals Business Overview
Table 124. Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Product
Table 125. Vertex Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million)
Table 126. Vertex Pharmaceuticals Recent Development
Table 127. WILEX AG Company Details
Table 128. WILEX AG Business Overview
Table 129. WILEX AG JAK and PI3K Signaling Pathway Product
Table 130. WILEX AG Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million)
Table 131. WILEX AG Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global JAK and PI3K Signaling Pathway Market Share by Type: 2020 VS 2027
Figure 2. PI3K Features
Figure 3. Janus Kinase Therapies (Inhibitors) Features
Figure 4. PI3K Therapies (Inhibitors) Features
Figure 5. Signal Transduction Biomarkers for JAK and PI3K Features
Figure 6. Global JAK and PI3K Signaling Pathway Market Share by Application: 2020 VS 2027
Figure 7. Cancer Case Studies
Figure 8. Inflammatory Diseases Case Studies
Figure 9. Cardiac Ailments Case Studies
Figure 10. Others Case Studies
Figure 11. JAK and PI3K Signaling Pathway Report Years Considered
Figure 12. Global JAK and PI3K Signaling Pathway Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global JAK and PI3K Signaling Pathway Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global JAK and PI3K Signaling Pathway Market Share by Regions: 2020 VS 2027
Figure 15. Global JAK and PI3K Signaling Pathway Market Share by Regions (2022-2027)
Figure 16. Global JAK and PI3K Signaling Pathway Market Share by Players in 2020
Figure 17. Global Top JAK and PI3K Signaling Pathway Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in JAK and PI3K Signaling Pathway as of 2020
Figure 18. The Top 10 and 5 Players Market Share by JAK and PI3K Signaling Pathway Revenue in 2020
Figure 19. Global JAK and PI3K Signaling Pathway Revenue Market Share by Type (2016-2021)
Figure 20. Global JAK and PI3K Signaling Pathway Revenue Market Share by Type (2022-2027)
Figure 21. North America JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America JAK and PI3K Signaling Pathway Market Share by Type (2016-2027)
Figure 23. North America JAK and PI3K Signaling Pathway Market Share by Application (2016-2027)
Figure 24. North America JAK and PI3K Signaling Pathway Market Share by Country (2016-2027)
Figure 25. United States JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe JAK and PI3K Signaling Pathway Market Share by Type (2016-2027)
Figure 29. Europe JAK and PI3K Signaling Pathway Market Share by Application (2016-2027)
Figure 30. Europe JAK and PI3K Signaling Pathway Market Share by Country (2016-2027)
Figure 31. Germany JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific JAK and PI3K Signaling Pathway Market Share by Type (2016-2027)
Figure 39. Asia-Pacific JAK and PI3K Signaling Pathway Market Share by Application (2016-2027)
Figure 40. Asia-Pacific JAK and PI3K Signaling Pathway Market Share by Region (2016-2027)
Figure 41. China JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America JAK and PI3K Signaling Pathway Market Share by Type (2016-2027)
Figure 49. Latin America JAK and PI3K Signaling Pathway Market Share by Application (2016-2027)
Figure 50. Latin America JAK and PI3K Signaling Pathway Market Share by Country (2016-2027)
Figure 51. Mexico JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa JAK and PI3K Signaling Pathway Market Share by Type (2016-2027)
Figure 55. Middle East & Africa JAK and PI3K Signaling Pathway Market Share by Application (2016-2027)
Figure 56. Middle East & Africa JAK and PI3K Signaling Pathway Market Share by Country (2016-2027)
Figure 57. Turkey JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Bayer HealthCare Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021)
Figure 61. AbbVie Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021)
Figure 63. Curis Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021)
Figure 64. Daiichi Sankyo Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021)
Figure 65. Exelixis Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021)
Figure 66. Genentech Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021)
Figure 67. Infinity Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021)
Figure 68. Merck & Co. Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021)
Figure 69. Rigel Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021)
Figure 70. TG Therapeutics Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021)
Figure 71. Sanofi Oncology Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021)
Figure 72. Vertex Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021)
Figure 73. WILEX AG Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5949 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、PI3キナーゼ（PI3K）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CLL-慢性リンパ性白血病、FL-濾胞性リンパ腫、その他疾患）、用途別市場規模（病院、研究所・研究機関、クリニック、その...

世界のヘッジホッグ経路阻害剤市場規模・現状・予測（2021年-2027年）

Global Hedgehog Pathway Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-4292 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ヘッジホッグ経路阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ビスモデギブ、エリスモデギブ、その他）、用途別市場規模（基底細胞癌（BCC）、急性リンパ芽球性白血病（AML）、その他）、主要地域...

世界のスマートシグナリング市場規模・現状・予測（2021年-2027年）

Global Smart Signaling Market Size, Status and Forecast 2021-2027
QFJ1-2275 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、スマートシグナリングの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ハードウェア、ソフトウェア、サービス）、用途別市場規模（都市交通、公共交通機関、高速道路、その他）、主要地域別市場規模（北米、アメリ...

世界の腫瘍血液検査市場規模・現状・予測（2021年-2027年）

Global Oncology Blood Testing Market Size, Status and Forecast 2021-2027
QFJ1-4605 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、腫瘍血液検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、乳がん、結腸直腸がん、前立腺がん、胃がん、その）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、ア...

世界の抗ニューロフィラメントL抗体市場規模・現状・予測（2021年-2027年）

Global Anti Neurofilament L Antibody Market Size, Status and Forecast 2021-2027
QFJ1-3816 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、抗ニューロフィラメントL抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（マウス抗ニューロフィラメントL抗体、ウサギ抗ニューロフィラメントL抗体、その他）、用途別市場規模（学術研究機関、製薬＆バイオ...

世界の類鼻疽診断市場規模・現状・予測（2021年-2027年）

Global Melioidosis Diagnostic Market Size, Status and Forecast 2021-2027
QFJ1-4489 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、類鼻疽診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（細菌培養試験、ラテックス固定試験、赤血球凝集アッセイ、蛍光抗体法、マトリックス支援レーザー脱離/イオン化、直接蛍光抗体試験、その他）、用途別市...

世界のアミロイドオリゴマー市場規模・現状・予測（2021年-2027年）

Global Amyloid Oligomer Market Size, Status and Forecast 2021-2027
QFJ1-3796 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、アミロイドオリゴマーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗体、検出試薬）、用途別市場規模（生物医学研究、AD治療、クイック診断）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の結腸直腸癌診断市場規模・現状・予測（2021年-2027年）

Global Colorectal Cancer Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-5128 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、結腸直腸癌診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（FOB検査、CTC検査、CEA検査、その他）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の炎症マーカー市場規模・現状・予測（2021年-2027年）

Global Inflammatory Marker Market Size, Status and Forecast 2021-2027
QFJ1-4365 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、炎症マーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（インターロイキン、C反応性蛋白、細胞接着分子、腫瘍壊死因子-α、その他）、用途別市場規模（病院、診断研究所、研究所、その他）、主要地域別市場...

世界のニュートリゲノミクス検査市場規模・現状・予測（2021年-2027年）

Global Nutrigenomics Testing Market Size, Status and Forecast 2021-2027
QFJ1-4601 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、ニュートリゲノミクス検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肥満、糖尿病、がん、循環器疾患、その他）、用途別市場規模（病院＆クリニック、オンラインプラットフォーム）、主要地域別市場規模（北...

世界のPI3キナーゼ（PI3K）阻害剤市場規模・現状・予測（2021年-2027年） PI3K inhibitors work by inhibiting PI3K enzymes, which helps in signaling the pathway for cellular functions such as growth control, metabolism, and translation initiation. There is extensive ongoing research on targeted therapies such as PI3K inhibitors with proven efficacy in oncology applications…
世界のヤヌスキナーゼ（JAK）阻害剤市場規模・現状・予測（2021年-2027年） JAK inhibitors are increasingly being used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis because of its proven efficacy in the treatment of various chronic diseases. The high unmet need for the treatment of graft-versus-host disease (GVHD) has also encouraged market vend…
世界のヘッジホッグ経路阻害剤市場規模・現状・予測（2021年-2027年） Hedgehog pathway inhibitors are small molecules that inhibit the activity of a component of the Hedgehog signaling pathway. Market Analysis and Insights: Global Hedgehog Pathway Inhibitors Market The global Hedgehog Pathway Inhibitors market size is projected to reach US$ XX million by 2027, from US…
世界のヤヌスキナーゼ（JAK）阻害剤産業調査2019-2025 Janus kinase inhibitors are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.In 2018, the global Janus Kinase (JAK) Inhibitors market size was xx milli…
世界のヤヌスキナーゼ（JAK）阻害剤産業調査2019-2025 Janus kinase inhibitors are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.In 2018, the global Janus Kinase (JAK) Inhibitors market size was xx milli…